Abbott Laboratories Inc. may seek another buyer for its diagnostics business after its $8 billion deal to sell it to GE Healthcare fell through, Wall Street analysts said on Thursday. The unit competes with Fullerton’s Beckman Coulter Inc.
*For more on this story,
read the full Reuters
article.
